U.S. stock market anomaly | Burnstone Medical (BNR.US) soars over 35%, with a total market value exceeding 86 million US dollars.

According to the Wisdom Finance APP, on Wednesday, Burning Stone Medicine (BNR.US) surged more than 35%, closing at $7.9, with a total market value exceeding $86 million. In terms of news, recently, Burning Stone Medicine has successfully completed 10 inter-laboratory quality assessments through the European Molecular Genetics Quality Network (EMQN), the College of American Pathologists (CAP), and others. The company used products such as Burning Stone OncoScreen Plus, OncoScreen WES, BRCA1/BRCA2 dual gene testing for white blood cells, Burning Stone Fukang, Burning Stone Langke blood version, Burning Stone Langqing (UMI), Burning Stone Kaikang, and Burning Stone Langkang for testing 28 samples. Up to now, Burning Stone Medicine has passed inter-laboratory quality assessments of NCCL, PQCC, EMQN, CAP, and other authoritative organizations internationally and domestically for 298 consecutive times.